Have to be, if we do an immune checkpoint inhibitor, patients have to have an IRA also, which is hypothyroidism or adrenal insufficiency. So this may cause the lifetime administration of additional hormone treatment. So it may cause some problem to the patient. So we need to distinguish the patients who need really intensive treatment or can be treated by conventional treatment...
Have to be, if we do an immune checkpoint inhibitor, patients have to have an IRA also, which is hypothyroidism or adrenal insufficiency. So this may cause the lifetime administration of additional hormone treatment. So it may cause some problem to the patient. So we need to distinguish the patients who need really intensive treatment or can be treated by conventional treatment. So it needs some more steps we require to make it possible.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.